COMMUNIQUÉS West-GlobeNewswire
-
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026 -
React19 Applauds Introduction of the Vaccine Injury Compensation Modernization Act of 2026
14/07/2026 -
Captain James A. Lovell Federal Health Care Center to Treat Post-Traumatic Stress With Virtual Reality Donated by Nonprofit SoldierStrong
14/07/2026 -
IBA – Information Réglementée
14/07/2026 -
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
14/07/2026 -
Inner Voyage Recovery Center earns BBB accreditation and A+ rating after eight years serving the Atlanta region
14/07/2026 -
Cherry Hills Recovery Opens July 13, Bringing Specialized Residential Care for Female Executives to Colorado
14/07/2026 -
Medicana Health Group Opens Belgrade Liaison Office to Strengthen Its Presence in the Balkans
14/07/2026 -
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
14/07/2026 -
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026 -
IBA – Regulated information
14/07/2026 -
Organic & Natural Health Association and India's SHEFEXIL Establish Strategic Partnership to Strengthen U.S.-India Supply Chain
14/07/2026 -
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
14/07/2026 -
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
14/07/2026 -
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
14/07/2026 -
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%
14/07/2026 -
Nordastro Launches Fully Personalized Astrology Book With Companion App for Daily Guidance
14/07/2026 -
FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer
14/07/2026 -
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
14/07/2026
Pages